Rudolph Nisi serves as Executive at RXI PHARMACEUTICALS CORP, where they oversee executive responsibilities. Since joining the company, Rudolph Nisi has executed 15 insider transactions totaling $2.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 10, 2017 involved receiving (via award) 17,130 shares valued at $6.5K.
Rudolph Nisi currently holds 42,918 shares of RXI PHARMACEUTICALS CORP (RXII), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rudolph Nisi has been a net seller of RXII stock. They have purchased $98.8K and sold $2.7M worth of shares.
Rudolph Nisi's most recent insider trade was on Oct 10, 2017, when they sold 17,130 shares at $0.38 per share.
Get notified when new Form 4 filings are submitted
| $0.59 |
| Discretionary |
| Jun 20, 2017 | GALE | $275 | Sale | 500 | $0.55 | Discretionary |
| Apr 10, 2017 | GALE | $6.4K | Award | 10,927 | $0.59 | Discretionary |
| Jan 20, 2017 | GALE | $6.5K | Award | 3,262 | $1.98 | Discretionary |
| Feb 7, 2014 | GALE | $98.8K | Purchase | 20,000 | $4.94 | Discretionary |
| Jan 29, 2014 | GALE | $115.5K | Option Exercise | 50,000 | $2.31 | Discretionary |
| Jan 29, 2014 | GALE | $36.0K | Option Exercise | 50,000 | $0.72 | Discretionary |
| Jan 29, 2014 | GALE | $1.3M | Sale | 250,000 | $5.28 | Discretionary |
| Jan 29, 2014 | GALE | $85.5K | Option Exercise | 50,000 | $1.71 | Discretionary |
| Jan 29, 2014 | GALE | $118.0K | Option Exercise | 100,000 | $1.18 | Discretionary |
| Jan 17, 2014 | GALE | $1.4M | Sale | 200,000 | $6.90 | Discretionary |
| Jan 15, 2014 | GALE | $118.0K | Option Exercise | 100,000 | $1.18 | Discretionary |
| Jan 15, 2014 | GALE | $85.0K | Option Exercise | 100,000 | $0.85 | Discretionary |
| Oct 16, 2009 | RXII | $0 | Award | 3,500 | $N/A | Discretionary |